MISTER SPEX SE (MRX.DE) Stock Fundamental Analysis

Europe • Frankfurt Stock Exchange • FRA:MRX • DE000A3CSAE2

1.445 EUR
+0.08 (+6.25%)
Last: Feb 4, 2026, 07:00 PM
Fundamental Rating

2

Taking everything into account, MRX scores 2 out of 10 in our fundamental rating. MRX was compared to 59 industry peers in the Specialty Retail industry. Both the profitability and financial health of MRX have multiple concerns. While showing a medium growth rate, MRX is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • MRX had negative earnings in the past year.
  • MRX had a negative operating cash flow in the past year.
  • In the past 5 years MRX always reported negative net income.
  • In the past 5 years MRX reported 4 times negative operating cash flow.
MRX.DE Yearly Net Income VS EBIT VS OCF VS FCFMRX.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M -80M

1.2 Ratios

  • The Return On Assets of MRX (-45.56%) is worse than 89.83% of its industry peers.
  • MRX has a worse Return On Equity (-119.72%) than 86.44% of its industry peers.
Industry RankSector Rank
ROA -45.56%
ROE -119.72%
ROIC N/A
ROA(3y)-27.31%
ROA(5y)-20%
ROE(3y)-57.09%
ROE(5y)-43%
ROIC(3y)N/A
ROIC(5y)N/A
MRX.DE Yearly ROA, ROE, ROICMRX.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80 -100

1.3 Margins

  • MRX's Gross Margin of 54.41% is amongst the best of the industry. MRX outperforms 83.05% of its industry peers.
  • In the last couple of years the Gross Margin of MRX has remained more or less at the same level.
  • The Profit Margin and Operating Margin are not available for MRX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 54.41%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.74%
GM growth 5Y0.94%
MRX.DE Yearly Profit, Operating, Gross MarginsMRX.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • MRX does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • MRX has more shares outstanding than it did 1 year ago.
  • MRX has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, MRX has a worse debt to assets ratio.
MRX.DE Yearly Shares OutstandingMRX.DE Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
MRX.DE Yearly Total Debt VS Total AssetsMRX.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

  • Based on the Altman-Z score of -2.42, we must say that MRX is in the distress zone and has some risk of bankruptcy.
  • MRX's Altman-Z score of -2.42 is on the low side compared to the rest of the industry. MRX is outperformed by 77.97% of its industry peers.
  • A Debt/Equity ratio of 0.81 indicates that MRX is somewhat dependend on debt financing.
  • MRX's Debt to Equity ratio of 0.81 is in line compared to the rest of the industry. MRX outperforms 42.37% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.81
Debt/FCF N/A
Altman-Z -2.42
ROIC/WACCN/A
WACC5.87%
MRX.DE Yearly LT Debt VS Equity VS FCFMRX.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

  • MRX has a Current Ratio of 2.31. This indicates that MRX is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 2.31, MRX belongs to the top of the industry, outperforming 88.14% of the companies in the same industry.
  • MRX has a Quick Ratio of 1.66. This is a normal value and indicates that MRX is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of MRX (1.66) is better than 91.53% of its industry peers.
Industry RankSector Rank
Current Ratio 2.31
Quick Ratio 1.66
MRX.DE Yearly Current Assets VS Current LiabilitesMRX.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • MRX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -26.68%.
  • The Revenue for MRX has decreased by -16.95% in the past year. This is quite bad
  • The Revenue has been growing by 9.25% on average over the past years. This is quite good.
EPS 1Y (TTM)-26.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%68.09%
Revenue 1Y (TTM)-16.95%
Revenue growth 3Y3.73%
Revenue growth 5Y9.25%
Sales Q2Q%-17.78%

3.2 Future

  • Based on estimates for the next years, MRX will show a very strong growth in Earnings Per Share. The EPS will grow by 22.29% on average per year.
  • Based on estimates for the next years, MRX will show a quite strong growth in Revenue. The Revenue will grow by 11.67% on average per year.
EPS Next Y54.33%
EPS Next 2Y31.15%
EPS Next 3Y22.29%
EPS Next 5YN/A
Revenue Next Year-15.23%
Revenue Next 2Y-6.06%
Revenue Next 3Y-2.53%
Revenue Next 5Y11.67%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
MRX.DE Yearly Revenue VS EstimatesMRX.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M
MRX.DE Yearly EPS VS EstimatesMRX.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 -0.5 -1 -1.5

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for MRX. In the last year negative earnings were reported.
  • Also next year MRX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MRX.DE Price Earnings VS Forward Price EarningsMRX.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MRX.DE Per share dataMRX.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

  • MRX's earnings are expected to grow with 22.29% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y31.15%
EPS Next 3Y22.29%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • MRX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

MISTER SPEX SE

FRA:MRX (2/4/2026, 7:00:00 PM)

1.445

+0.08 (+6.25%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)11-13
Earnings (Next)N/A
Inst Owners21.74%
Inst Owner ChangeN/A
Ins Owners15.2%
Ins Owner ChangeN/A
Market Cap50.65M
Revenue(TTM)185.36M
Net Income(TTM)-68.92M
Analysts77.5
Price Target4.42 (205.88%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1%
Min Revenue beat(2)-1.02%
Max Revenue beat(2)-0.98%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-1.73%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.21%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.27
P/FCF N/A
P/OCF N/A
P/B 0.88
P/tB 0.93
EV/EBITDA N/A
EPS(TTM)-2.09
EYN/A
EPS(NY)-0.42
Fwd EYN/A
FCF(TTM)-0.26
FCFYN/A
OCF(TTM)-0.15
OCFYN/A
SpS5.29
BVpS1.64
TBVpS1.55
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -45.56%
ROE -119.72%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 54.41%
FCFM N/A
ROA(3y)-27.31%
ROA(5y)-20%
ROE(3y)-57.09%
ROE(5y)-43%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.74%
GM growth 5Y0.94%
F-Score4
Asset Turnover1.23
Health
Industry RankSector Rank
Debt/Equity 0.81
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 7.61%
Cap/Sales 2.05%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.31
Quick Ratio 1.66
Altman-Z -2.42
F-Score4
WACC5.87%
ROIC/WACCN/A
Cap/Depr(3y)41.44%
Cap/Depr(5y)71.03%
Cap/Sales(3y)6.28%
Cap/Sales(5y)7.09%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-26.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%68.09%
EPS Next Y54.33%
EPS Next 2Y31.15%
EPS Next 3Y22.29%
EPS Next 5YN/A
Revenue 1Y (TTM)-16.95%
Revenue growth 3Y3.73%
Revenue growth 5Y9.25%
Sales Q2Q%-17.78%
Revenue Next Year-15.23%
Revenue Next 2Y-6.06%
Revenue Next 3Y-2.53%
Revenue Next 5Y11.67%
EBIT growth 1Y-29.66%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year98.35%
EBIT Next 3Y32.46%
EBIT Next 5Y29.96%
FCF growth 1Y50.44%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-711.8%
OCF growth 3YN/A
OCF growth 5YN/A

MISTER SPEX SE / MRX.DE FAQ

What is the fundamental rating for MRX stock?

ChartMill assigns a fundamental rating of 2 / 10 to MRX.DE.


What is the valuation status for MRX stock?

ChartMill assigns a valuation rating of 1 / 10 to MISTER SPEX SE (MRX.DE). This can be considered as Overvalued.


Can you provide the profitability details for MISTER SPEX SE?

MISTER SPEX SE (MRX.DE) has a profitability rating of 1 / 10.


What is the earnings growth outlook for MISTER SPEX SE?

The Earnings per Share (EPS) of MISTER SPEX SE (MRX.DE) is expected to grow by 54.33% in the next year.